CoreBone

Bioactive Coral-based Bone Graft

Startup

CoreBone is a startup in the Health Tech & Life Sciences sector, established in 2011. Bioactive Coral-based Bone Graft . The company has raised a total of $6.32M across 3 funding rounds, currently at the A stage. CoreBone was founded by Ohad Schwartz and Prof. Itzhak Binderman. Key investors include Guangzhou Sino-Israel Biotech Investment Fund (GIBF), Agriline, The Trendlines Group, among 5 total investors. The company has 1-10 employees. Core technologies: Materials & Substances, Biologicals.

With $6.32M in total funding, CoreBone is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.

$6.32M
Raised
3
Rounds
5
Investors
2
Team
2011
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringMaterials & SubstancesBiologicals
At a Glance
Investors

5 investors total

Founders
In the News

4 articles covered by sources including www.prnewswire.com, www.israel21c.org, nocamels.com.

www.prnewswire.com · Oct 3, 2021
CoreBone Raises $3.7 Million Investment to Commercialize its Bioactive Bone Graft Material for Dental and Orthopedic Treatments & Expand Activity in China
Read article ↗
Frequently Asked Questions
What does CoreBone do?

CoreBone has developed a strong, bioactive coral bone graft for dental and orthopedic indications. The biomimetic bone graft offers a set of bonelike qualities, such as strength, porosity, resorption, and bioactivity, without being derived from human or animal bone. The companys bone graft is made from coral that is cultured in a closely monitored system, providing better control in enriching the graft with silicium and strontium for bioactivity and increased strength. CoreBone has been awarded CE approval, and FDA 510K submission is planned for mid-2017. CoreBone products are CE and ISO 13485 certified.

How much funding has CoreBone raised?

CoreBone has raised $6.32M in total funding across 3 rounds. The company is currently at the A stage. Key investors include Guangzhou Sino-Israel Biotech Investment Fund (GIBF), Agriline, The Trendlines Group.

Who founded CoreBone?

CoreBone was founded in 2011 by Ohad Schwartz (Co-founder & CEO), Prof. Itzhak Binderman (Co-founder).

What sector is CoreBone in?

CoreBone operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Biomaterials & Tissue Engineering, with core technologies in Materials & Substances, Biologicals. Target customers: Commerce & Retail, Distribution Channels, Distributor, Healthcare & Life Sciences, Healthcare, Providers.

Where is CoreBone located?

CoreBone is based in Misgav, Israel.

View Full Profile Classic View Website ↗